DrugID Drug_Name DiseaseID Disease_entry ICD11 Highest_status DR00001 Fesoterodine fumarate DIS0143 Overactive bladder disorder GC50.0 Approved DR00002 Paraquat DIS0058 Discovery agent N.A. Investigative DR00003 Lisdexamfetamine DIS0026 Attention deficit hyperactivity disorder 6A05 Approved DR00004 Gaboxadol DIS0104 Insomnia 7A0Z Discontinued in Phase 3 DR00005 L-glutamic acid DIS0098 Indigestion DD90 Approved DR00005 L-glutamic acid DIS0165 Schizophrenia 6A20 Approved DR00006 Moexipril DIS0082 High blood pressure BA00 Approved DR00007 Prostaglandin f2Alpha DIS0170 Solid tumours 2D4Z Preclinical DR00008 Venetoclax DIS0039 Chronic lymphocytic leukemia 2A82.0 Approved DR00009 Nitrate DIS0720 Stable angina BA40.1 Phase 4 DR00010 Enalapril DIS0082 High blood pressure BA00 Approved DR00011 2-Deoxyglucose DIS0031 Cancer 2A00-2F9Z Phase 1/2 DR00013 Nilotinib DIS0040 Chronic myelogenous leukemia 2A20.0 Approved DR00014 Simeprevir DIS0037 Chronic hepatitis C infection 1E51.1 Approved DR00015 Adefovir DIS0231 Hepatitis B virus infection 1E51.0, 1E50.1 Approved DR00015 Adefovir DIS0232 Herpes simplex virus infection 1F00 Approved DR00016 Meperidine DIS0122 Moderate to severe pain MG30-MG3Z Approved DR00017 Tiotropium DIS0041 Chronic obstructive pulmonary disease CA22 Approved DR00019 Estrone sulfate DIS0748 Menopausal symptoms MF32 Approved DR00020 L-tyrosine DIS0057 Dietary shortage 5B7Z Approved DR00021 Teniposide DIS0005 Acute lymphoblastic leukemia 2B33.0 Approved DR00022 Oxalate DIS0058 Discovery agent N.A. Investigative DR00023 Memantine DIS0015 Alzheimer disease 8A20 Approved DR00024 L-glutamine DIS0168 Short bowel syndrome KB89.1 Approved DR00025 Triethylcholine DIS0278 Glaucoma 9C61 Preclinical DR00026 Fexofenadine DIS0013 Allergic rhinitis CA08.0 Approved DR00027 Ganciclovir DIS0049 Cytomegalovirus infections 1D82 Approved DR00028 Etilefrine DIS0637 Hypotension BA2Z Withdrawn DR00029 Moxidectin DIS0137 Onchocerciasis 1F6A Approved DR00030 Atorvastatin DIS0638 Heart attack BA41.Z Approved DR00030 Atorvastatin DIS0063 Dyslipidaemias 5C8Z Approved DR00030 Atorvastatin DIS0194 Hyperlipidaemia 5C8Z Approved DR00031 Ramipril DIS0046 Congestive heart failure BD10 Approved DR00031 Ramipril DIS0082 High blood pressure BA00 Approved DR00032 Imatinib DIS0621 Gastrointestinal stromal tumor 2B5B Approved DR00032 Imatinib DIS0040 Chronic myelogenous leukemia 2A20.0 Approved DR00033 Atenolol DIS0082 High blood pressure BA00 Approved DR00034 Creatine ALS-08 DIS0123 Motor neurone disease 8B60 Phase 3 DR00035 Axitinib DIS0010 Advanced renal cell carcinoma 2C90 Approved DR00036 Cholesterol DIS0721 Cone-Rod dystrophy 9B70 Phase 2 DR00037 Cimetidine DIS0001 Acid reflux disorder DA22 Approved DR00038 Sodium bicarbonate DIS0116 Metabolic acidosis 5C73 Approved DR00039 Glutathione DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00040 Amantadine DIS0102 Influenza A infection 1.00E+31 Approved DR00041 Pralatrexate DIS0030 Breast cancer 2C60-2C6Z Approved DR00041 Pralatrexate DIS0150 Peripheral T-cell lymphoma 2A90.C Approved DR00043 Fructose DIS0066 Emesis MD90 Approved DR00044 Topotecan DIS0142 Ovarian cancer 2C73 Approved DR00045 Pravastatin DIS0087 Hypercholesterolemia 5C80.0 Approved DR00046 Levofloxacin DIS0598 Gram-positive & negative bacteria infections 1A00-1H0Z Approved DR00047 D-serine DIS0239 Serine deficiency disorder 5C50.6 Phase 4 DR00048 Urea DIS0052 Dermatological disease EA00-EM0Z Preclinical DR00049 Levomilnacipran DIS0074 Fibromyalgia MG30.01 Approved DR00050 Erythromycin DIS0605 Syphilis 1A60-1A6Z Approved DR00050 Erythromycin DIS0612 Chlamydia infections 1C2Z Approved DR00050 Erythromycin DIS0643 Pelvic inflammatory disease GA05 Approved DR00053 Sodium taurocholate DIS0178 Type 2 diabetes 5A11 Preclinical DR00054 Quinine DIS0111 Malaria 1F40 Approved DR00055 Codeine DIS0144 Pain MG30-MG7Z Approved DR00056 Lamotrigine DIS0029 Bipolar disorder 6A60-6A61 Approved DR00056 Lamotrigine DIS0069 Epilepsy 8A6Z Approved DR00057 Aminolevulinic acid DIS0151 Photodynamic therapy EK90.0 Approved DR00058 Perindopril DIS0082 High blood pressure BA00 Approved DR00059 Tolvaptan DIS0071 Euvolaemic hyponatraemia 5C72 Approved DR00059 Tolvaptan DIS0092 Hypervolaemic hyponatraemia 5C72 Approved DR00060 Sulfate DIS0058 Discovery agent N.A. Investigative DR00061 Aliskiren fumarate DIS0082 High blood pressure BA00 Approved DR00063 Gemcitabine DIS0145 Pancreatic cancer 2C10 Approved DR00063 Gemcitabine DIS0227 Cholangiocarcinoma 2C12.10 Approved DR00064 Indacaterol DIS0041 Chronic obstructive pulmonary disease CA22 Approved DR00065 L-ornithine DIS0781 Immunomodulatory and wound-healing EL8Y Preclinical DR00066 Cidofovir DIS0049 Cytomegalovirus infections 1D82 Approved DR00067 Aminohippuric acid DIS0782 Renal function tests MG02 Withdrawn DR00068 Zinc salts DIS0021 Arthritis FA5Z Preclinical DR00069 Cabergoline DIS0089 Hyperprolactinemia 5A60.1 Approved DR00070 Acetylcholine DIS0034 Cataract 9B10 Approved DR00071 Valsartan DIS0082 High blood pressure BA00 Approved DR00072 Lifitegrast DIS0061 Dry eye disease 9A79 Approved DR00073 Rifaximin DIS0647 Traveler's diarrhea ME05.1 Approved DR00073 Rifaximin DIS0108 Irritable bowel syndrome DD91.0 Approved DR00074 Allopurinol DIS0091 Hyperuricaemia 5C55.Y Approved DR00075 Asunaprevir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Phase 3 DR00076 Epinephrine DIS0014 Allergy 4A8Z Approved DR00076 Epinephrine DIS0023 Asthma CA23 Approved DR00077 Brilinta DIS0174 Thrombosis BD71.4, BD72 Approved DR00078 Valacyclovir DIS0232 Herpes simplex virus infection 1F00 Approved DR00078 Valacyclovir DIS0615 Shingles 1.00E+91 Approved DR00079 Riboflavin DIS0002 Acne vulgaris ED80 Approved DR00080 Riociguat DIS0159 Pulmonary arterial hypertension BB01.0 Approved DR00081 Ergotidine DIS0298 Migraine 8A80 Approved DR00082 Methotrexate DIS0110 Leukemia 2A60-2B33 Approved DR00083 Glutarate DIS0058 Discovery agent N.A. Investigative DR00084 Amphetamine DIS0026 Attention deficit hyperactivity disorder 6A05 Approved DR00085 Pentamidine DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00086 L-tryptophan DIS0051 Depression 6A8Z Approved DR00087 Cladribine DIS0078 Hairy cell leukemia 2A82.2 Approved DR00088 Tramadol DIS0144 Pain MG30-MG7Z Approved DR00089 Gabapentin enacarbil DIS0235 Postherpetic neuralgia 1E91.5 Approved DR00090 UDP-xylose DIS0058 Discovery agent N.A. Investigative DR00091 Dimesna DIS0055 Diabetic nephropathy GB61 Phase 3 DR00092 Teriflunomide DIS0125 Multiple scierosis 8A40 Approved DR00093 Latanoprostene bunod DIS0160 Renal cell carcinoma 2C90 Approved DR00094 Glibenclamide DIS0053 Diabetes 5A10-5A14 Approved DR00095 Spirapril DIS0082 High blood pressure BA00 Approved DR00096 Trifluridine DIS0232 Herpes simplex virus infection 1F00 Approved DR00097 Abemaciclib DIS0030 Breast cancer 2C60-2C6Z Approved DR00098 Glucose-6-phosphate DIS0634 High blood glucose 5C61.5 Phase 1 DR00099 Iloprost DIS0159 Pulmonary arterial hypertension BB01.0 Approved DR00100 Adenosine monophosphate DIS0057 Dietary shortage 5B7Z Approved DR00101 Edaravone DIS0017 Amyotrophic lateral sclerosis 8B60.0 Approved DR00102 Dinoprostone DIS0113 Medical abortion JA00.1 Approved DR00103 Ethinyl estradiol DIS0072 Female hypogonadism 5A61.0 Approved DR00104 Tolbutamide DIS0131 Non insulin dependent diabetes 5A11 Approved DR00105 S-adenosylmethionine DIS0714 Alcoholic liver disease DB94 Phase 3 DR00106 Tetraethylammonium DIS0194 Hyperlipidaemia 5C8Z Phase 2 DR00107 Levothyroxine DIS0094 Hypothyroidism 5A00.2 Approved DR00108 Testosterone DIS0141 Osteoporosis FB83.1 Approved DR00110 YM155 DIS0030 Breast cancer 2C60-2C6Z Phase 2 DR00110 YM155 DIS0129 Non hodgkin's lymphoma 2A8Z Phase 2 DR00111 Posaconazole DIS0022 Aspergillosis 1F20 Approved DR00112 Irinotecan DIS0043 Colorectal cancer 2B91 Approved DR00113 Azathioprine DIS0140 Organ transplant rejection NE84 Approved DR00114 CMP-sialic acid DIS0058 Discovery agent N.A. Investigative DR00115 Lysine DIS0165 Schizophrenia 6A20 preclinical DR00116 Lamivudine DIS0038 Chronic hepatitis B infection 1E51.0 Approved DR00116 Lamivudine DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00117 Vitamin B1 DIS0184 Vitamin B1 deficiency 5B5A Approved DR00118 Sphingosine-1-phosphate DIS0002 Acne vulgaris ED80 Phase 1 DR00119 Arsenic trioxide DIS0005 Acute lymphoblastic leukemia 2B33.0 Approved DR00120 Lapatinib DIS0030 Breast cancer 2C60-2C6Z Approved DR00121 Choline DIS0723 Elderly bronchial asthma CA23 Phase 3 DR00122 MYO-inositol DIS0240 Polycystic ovary syndrome 5A80.1 Phase 4 DR00123 Oxypurinol DIS0081 Heart failure BD1Z Phase 2/3 DR00124 Fluvastatin DIS0087 Hypercholesterolemia 5C80.0 Approved DR00125 Levodopa DIS0146 Parkinson's Disease 8A00.0 Approved DR00126 Adenine DIS0057 Dietary shortage 5B7Z Approved DR00127 Tetracycline DIS0598 Gram-positive & negative bacteria infections 1A00-1H0Z Approved DR00128 Methylprednisolone DIS0041 Chronic obstructive pulmonary disease CA22 Approved DR00128 Methylprednisolone DIS0023 Asthma CA23 Approved DR00128 Methylprednisolone DIS0175 Tuberculosis 1B1Z Approved DR00128 Methylprednisolone DIS0632 Systemic lupus erythematosus 4A40.0 Approved DR00129 Estradiol DIS0030 Breast cancer 2C60-2C6Z Approved DR00130 Leflunomide DIS0003 Active rheumatoid arthritis FA20 Approved DR00130 Leflunomide DIS0125 Multiple scierosis 8A40 Preclinical DR00131 Sucrose DIS0716 Retinopathy of prematurity 9B71.3 Phase 4 DR00132 Phosphate DIS0047 Constipation ME05.0 Approved DR00133 Metformin DIS0178 Type 2 diabetes 5A11 Approved DR00134 Folic acid DIS0186 Vitamin deficiency 5B55-5B7Z Approved DR00135 Colchicine DIS0004 Acute gouty arthritis FA25 Approved DR00136 Regorafenib DIS0118 Metastatic colorectal cancer 2B91 Approved DR00137 Nintedanib DIS0096 Idiopathic pulmonary fibrosis CB03.4 Approved DR00138 Bicarbonate DIS0116 Metabolic acidosis 5C73 Phase 3 DR00139 Alpha-ketoglutaric acid DIS0058 Discovery agent N.A. Investigative DR00140 Ezetimibe DIS0087 Hypercholesterolemia 5C80.0 Approved DR00141 Methadone DIS0144 Pain MG30-MG7Z Approved DR00141 Methadone DIS0154 Opioid type drug dependence 6C43 Approved DR00142 L-alanine DIS0057 Dietary shortage 5B7Z Approved DR00142 L-alanine DIS0075 Glioma 2A00.0 Approved DR00143 Vincristine DIS0005 Acute lymphoblastic leukemia 2B33.0 Approved DR00144 Daclatasvir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Approved DR00145 Mercaptopurine DIS0005 Acute lymphoblastic leukemia 2B33.0 Approved DR00146 Deflazacort DIS0062 Duchenne muscular dystrophy 8C70.1 Approved DR00147 Ivermectin DIS0106 Strongyloidiasis due to nematode parasite 1F6B Approved DR00148 Digoxin DIS0020 Arrhythmias BC60-BC9Z Approved DR00148 Digoxin DIS0081 Heart failure BD1Z Approved DR00149 Eluxadoline DIS0056 Diarrhea-predominant irritable bowel syndrome DD91.01 Approved DR00150 Acetyl-l-carnitine DIS0412 Migraine 8A80 Phase 4 DR00151 Pomalidomide DIS0173 Systemic sclerosis 4A42.0 Approved DR00152 Oleic acid DIS0719 Colorectal Adenomatous Polyps DB35 Phase 2 DR00153 Fluorouracil DIS0228 Colon cancer 2B90.Z Approved DR00153 Fluorouracil DIS0622 Esophageal cancer 2B70 Approved DR00153 Fluorouracil DIS0624 Stomach cancer 2B72 Approved DR00153 Fluorouracil DIS0145 Pancreatic cancer 2C10 Approved DR00154 Tretinoin DIS0002 Acne vulgaris ED80 Approved DR00155 Ouabain DIS0024 Atrial fibrillation BC81.3 Approved DR00155 Ouabain DIS0081 Heart failure BD1Z Approved DR00156 Propionate DIS0058 Discovery agent N.A. Investigative DR00157 Orotate DIS0058 Discovery agent N.A. Investigative DR00158 Glimepiride DIS0053 Diabetes 5A10-5A14 Approved DR00159 Paliperidone DIS0165 Schizophrenia 6A20 Approved DR00160 GDP-fucose DIS0058 Discovery agent N.A. Investigative DR00161 SN-38 DIS0228 Colon cancer 2B90.Z Phase 2 DR00162 Etoposide DIS0630 Testicular cancer 2C80 Approved DR00162 Etoposide DIS0109 Kaposi's sarcoma 2B57 Approved DR00162 Etoposide DIS0620 Ewing's sarcoma 2B52 Approved DR00162 Etoposide DIS0626 Lung cancer 2C25 Approved DR00163 Ranitidine DIS0149 Peptic ulcer DA61 Approved DR00164 Dabrafenib DIS0114 Melanoma 2C30 Approved DR00165 D-glucose DIS0784 Hypoglycemia 5A21; 5A41 Approved DR00166 Edoxaban DIS0024 Atrial fibrillation BC81.3 Approved DR00167 Taurine DIS0046 Congestive heart failure BD10 Phase 4 DR00168 Latanoprost DIS0136 Ocular hypertension 9C61.01 Approved DR00168 Latanoprost DIS0138 Open angle glaucoma 9C61 Approved DR00170 Epirubicin DIS0628 Node-positive breast cancer 2C60-2C6Z Approved DR00171 Loperamide DIS0007 Acute diarrhea ME05.1 Approved DR00172 Uric acid DIS0715 Acute ischemic stroke 8B11 Phase 2/3 DR00173 Liothyronine DIS0094 Hypothyroidism 5A00.2 Approved DR00174 Tenofovir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00175 Zalcitabine DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00176 Ribavirin DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Approved DR00177 Cetirizine DIS0013 Allergic rhinitis CA08.0 Approved DR00178 UDP-glucose DIS0058 Discovery agent N.A. Investigative DR00179 L-proline DIS0057 Dietary shortage 5B7Z Approved DR00180 Levetiracetam DIS0069 Epilepsy 8A6Z Approved DR00181 Panobinostat DIS0124 Multiple myeloma 2A83 Approved DR00182 Dasatinib DIS0124 Multiple myeloma 2A83 Approved DR00183 Tacrine DIS0015 Alzheimer disease 8A20 Approved DR00184 Potassium chloride DIS0093 Hypokalemia 5C77 Approved DR00185 Pazopanib hydrochloride DIS0160 Renal cell carcinoma 2C90 Approved DR00186 Relugolix DIS0067 Endometriosis GA10 Phase 3 DR00187 Prucalopride DIS0241 Chronic idiopathic constipation ME05.0 Approved DR00188 Arginine DIS0077 Growth hormone deficiency 5A61 Approved DR00189 Serotonin DIS0058 Discovery agent N.A. Investigative DR00190 Amoxicillin DIS0608 Streptococcal pharyngitis 1B51 Approved DR00191 Theophylline DIS0041 Chronic obstructive pulmonary disease CA22 Approved DR00192 L-homoarginine DIS0715 Acute ischemic stroke 8B11 preclinical DR00193 Tamoxifen DIS0030 Breast cancer 2C60-2C6Z Approved DR00194 Ammonia DIS0048 Coronary artery disease BA6Z Preclinical DR00195 Rhodamine 123 DIS0157 Prostate cancer 2C82 Discontinued in Phase 1 DR00196 Rifampicin DIS0175 Tuberculosis 1B1Z Approved DR00197 Cycloserine DIS0050 Dementia 6D8Z Approved DR00197 Cycloserine DIS0175 Tuberculosis 1B1Z Approved DR00198 Fucose DIS0729 Type 2 leukocyte adhesion deficiency 5C54.2 Phase 1/2 DR00201 Sulfasalazine DIS0100 Inflammatory bowel disease DD7Z Approved DR00201 Sulfasalazine DIS0163 Rheumatoid arthritis FA20 Approved DR00202 D-mannose DIS0320 Urinary tract infections GC08 Phase 4 DR00203 Aspirin DIS0144 Pain MG30-MG7Z Approved DR00204 Ponatinib DIS0005 Acute lymphoblastic leukemia 2B33.0 Approved DR00205 Riluzole DIS0017 Amyotrophic lateral sclerosis 8B60.0 Approved DR00206 Pitavastatin calcium DIS0063 Dyslipidaemias 5C8Z Approved DR00207 Amiloride DIS0046 Congestive heart failure BD10 Approved DR00207 Amiloride DIS0082 High blood pressure BA00 Approved DR00208 Estradiol-17beta-glucuronide DIS0058 Discovery agent N.A. Investigative DR00209 Verteporfin DIS0703 Age-related macular degeneration 9B75.0 Approved DR00210 Alprostadil DIS0070 Erectile dysfunction HA01 Approved DR00211 Apixaban DIS0174 Thrombosis BD71.4, BD72 Approved DR00212 Clomiphene citrate DIS0073 Female infertility due to anovulation GA31 Approved DR00213 Sincalide DIS0058 Discovery agent N.A. preclinical DR00214 L-isoleucine DIS0058 Discovery agent N.A. Investigative DR00215 Dexamethasone DIS0163 Rheumatoid arthritis FA20 Approved DR00216 Betrixaban DIS0181 Venous thromboembolism BD72 Approved DR00217 Gabapentin DIS0147 Partial seizures 8A68.0 Approved DR00218 Alpha-oxoadipic acid DIS0058 Discovery agent N.A. Investigative DR00219 Idelalisib DIS0039 Chronic lymphocytic leukemia 2A82.0 Approved DR00220 Eliglustat tartrate DIS0117 Metabolic disorders 5C50 Approved DR00221 Olaparib DIS0030 Breast cancer 2C60-2C6Z Approved DR00221 Olaparib DIS0142 Ovarian cancer 2C73 Approved DR00222 Torsemide DIS0065 Edema associated with congestive heart failure BD10 Approved DR00223 Rosuvastatin DIS0087 Hypercholesterolemia 5C80.0 Approved DR00224 Everolimus DIS0160 Renal cell carcinoma 2C90 Approved DR00225 Quercetin DIS0048 Coronary artery disease BA6Z Phase 3 DR00225 Quercetin DIS0134 Obesity 5B81 Phase 3 DR00226 Saxagliptin DIS0178 Type 2 diabetes 5A11 Approved DR00227 Rivaroxaban DIS0156 Prophylaxis of deep vein thrombosis BD71 Approved DR00228 Ceritinib DIS0132 Non-small cell lung cancer 2C25 Approved DR00229 Ochratoxin A DIS0058 Discovery agent N.A. Investigative DR00230 Hydrocortisone DIS0101 Inflammatory disease 9B72 Approved DR00231 Lysophosphatidylcholine DIS0058 Discovery agent N.A. Investigative DR00232 Probenecid DIS0076 Gout FA25 Approved DR00232 Probenecid DIS0091 Hyperuricaemia 5C55.Y Approved DR00233 Romidepsin DIS0617 Cutaneous T-cell lymphoma 2B0Z Approved DR00233 Romidepsin DIS0150 Peripheral T-cell lymphoma 2A90.C Approved DR00235 Flavopiridol DIS0039 Chronic lymphocytic leukemia 2A82.0 Phase 2 DR00236 L-valine DIS0193 Traumatic brain injury NA07.Z preclinical DR00237 Varenicline DIS0169 Smoking cessation 6C4A.2 Approved DR00238 Leucovorin DIS0043 Colorectal cancer 2B91 Approved DR00239 Digitoxin DIS0604 Kidney disorder GB90 Approved DR00239 Digitoxin DIS0081 Heart failure BD1Z Approved DR00240 Trandolapril DIS0082 High blood pressure BA00 Approved DR00241 Dabigatran DIS0171 Stroke in atrial fibrillation 8B11.20 Approved DR00242 Glycine DIS0057 Dietary shortage 5B7Z Approved DR00243 Mycophenolate mofetil DIS0148 Pemphigus vulgaris EB40.0 Approved DR00244 L-threonine DIS0440 Ulcerative colitis DD71 preclinical DR00245 Clopidogrel DIS0174 Thrombosis BD71.4, BD72 Approved DR00246 Ranolazine DIS0035 Chronic angina BA40 Approved DR00247 Vasopressin DIS0053 Diabetes 5A10-5A14 Approved DR00247 Vasopressin DIS0068 Enuresis 6C00 Approved DR00247 Vasopressin DIS0152 Polyuria MF55 Approved DR00248 Telmisartan DIS0082 High blood pressure BA00 Approved DR00249 Cannabidiol DIS0237 Lennox-Gastaut syndrome 8A62.1 Approved DR00249 Cannabidiol DIS0238 Dravet syndrome 8A61.11 Approved DR00250 Oseltamivir DIS0103 Influenza virus 1E30-1E32 Approved DR00251 Docetaxel DIS0030 Breast cancer 2C60-2C6Z Approved DR00251 Docetaxel DIS0626 Lung cancer 2C25 Approved DR00251 Docetaxel DIS0157 Prostate cancer 2C82 Approved DR00251 Docetaxel DIS0623 Gastric cancer 2B72 Approved DR00251 Docetaxel DIS0080 Head and neck cancer 2B60-2B6E Approved DR00251 Docetaxel DIS0142 Ovarian cancer 2C73 Approved DR00252 Bilirubin DIS0058 Discovery agent N.A. Investigative DR00253 Bosutinib DIS0040 Chronic myelogenous leukemia 2A20.0 Approved DR00254 Sitagliptin DIS0178 Type 2 diabetes 5A11 Approved DR00255 L-carnitine DIS0133 Nutritional deficiency 5B7Z Approved DR00256 Methamphetamine DIS0026 Attention deficit hyperactivity disorder 6A05 Approved DR00257 Biotin DIS0731 Biotin ingestion 5B5G Phase 4 DR00258 Furosemide DIS0065 Edema associated with congestive heart failure BD10 Approved DR00259 Cefaclor DIS0598 Gram-positive & negative bacteria infections 1A00-1H0Z Approved DR00260 Dehydroascorbic acid DIS0058 Discovery agent N.A. Investigative DR00261 Lenalidomide DIS0018 Anaemia 3A9Z Approved DR00261 Lenalidomide DIS0124 Multiple myeloma 2A83 Approved DR00262 Sirolimus DIS0140 Organ transplant rejection NE84 Approved DR00263 Nizatidine DIS0001 Acid reflux disorder DA22 Approved DR00264 Verapamil DIS0019 Angina BA40 Approved DR00264 Verapamil DIS0082 High blood pressure BA00 Approved DR00265 Lenvatinib DIS0142 Ovarian cancer 2C73 Approved DR00266 L-phenylalanine DIS0057 Dietary shortage 5B7Z Approved DR00267 Indomethacin DIS0121 Moderate to severe rheumatoid arthritis FA20 Approved DR00268 Norepinephrine DIS0128 Neurogenic shock MG40.Y Approved DR00268 Norepinephrine DIS0167 Septic shock 1G41 Approved DR00269 Mitoxantrone DIS0619 Non-hodgkin's lymphoma 2B33.5 Approved DR00269 Mitoxantrone DIS0629 Metastatic breast cancer 2C6Y Approved DR00269 Mitoxantrone DIS0006 Acute myeloid leukemia 2A60 Approved DR00270 Vigabatrin DIS0044 Complex partial seizure 8A6Z Approved DR00270 Vigabatrin DIS0069 Epilepsy 8A6Z Approved DR00270 Vigabatrin DIS0099 Infantile spasm 8A62.0 Approved DR00271 Empagliflozin DIS0176 Type 1 diabetes 5A10 Approved DR00272 Bumetanide DIS0065 Edema associated with congestive heart failure BD10 Approved DR00273 Danoprevir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Phase 2 DR00274 Docosahexaenoic acid DIS0015 Alzheimer disease 8A20 Phase 3 DR00275 Bestatin DIS0006 Acute myeloid leukemia 2A60 Approved DR00277 Ipratropium DIS0135 Obstructive lung diseases CA22.Z Approved DR00278 Famotidine DIS0149 Peptic ulcer DA61 Approved DR00279 Canagliflozin DIS0178 Type 2 diabetes 5A11 Approved DR00280 Nicardipine DIS0019 Angina BA40 Approved DR00280 Nicardipine DIS0082 High blood pressure BA00 Approved DR00281 Progesterone DIS0155 Premature labour JB00 Approved DR00282 L-histidine DIS0725 HARS Syndrome N.A. Phase 2/3 DR00283 Dopamine DIS0146 Parkinson's Disease 8A00.0 Approved DR00284 Daunorubicin DIS0006 Acute myeloid leukemia 2A60 Approved DR00285 Silodosin DIS0028 Benign prostatic hyperplasia GA90 Approved DR00286 Benazepril DIS0082 High blood pressure BA00 Approved DR00287 Resveratrol DIS0043 Colorectal cancer 2B91 Discontinued in Phase 2 DR00288 Bosentan DIS0159 Pulmonary arterial hypertension BB01.0 Approved DR00289 Vitamin C DIS0185 Vitamin C deficiency 5B56 Approved DR00290 Lopinavir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00291 Cisplatin DIS0142 Ovarian cancer 2C73 Approved DR00291 Cisplatin DIS0627 Sarcomas 2C35 Approved DR00291 Cisplatin DIS0630 Testicular cancer 2C80 Approved DR00292 Procainamide DIS0182 Ventricular arrhythmias BC71 Approved DR00293 Pyroglutamic acid DIS0058 Discovery agent N.A. Investigative DR00294 Phosphatidylethanolamine DIS0058 Discovery agent N.A. Investigative DR00295 Cyclic adenosine monophosphate DIS0058 Discovery agent N.A. Investigative DR00296 Zidovudine DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00298 Heme DIS0058 Discovery agent N.A. Investigative DR00299 Indinavir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00300 Fostamatinib DIS0163 Rheumatoid arthritis FA20 Approved DR00301 Doxorubicin DIS0110 Leukemia 2A60-2B33 Approved DR00301 Doxorubicin DIS0084 Hodgkin lymphoma 2B30 Approved DR00302 Coenzyme A DIS0401 Hyperlipoproteinemia 5C80 Phase 3 DR00303 L-leucine DIS0189 Major depressive disorder 6A70.3 Phase 2 DR00304 Sorafenib DIS0625 Hepatocellular carcinoma 2C12.02 Approved DR00304 Sorafenib DIS0160 Renal cell carcinoma 2C90 Approved DR00304 Sorafenib DIS0631 Differentiated thyroid cancer 2D10 Approved DR00304 Sorafenib DIS0145 Pancreatic cancer 2C10 Approved DR00305 Bromsulphthalein DIS0058 Discovery agent N.A. Investigative DR00306 Beta-alanine DIS0728 Muscle function VC01 Phase 4 DR00307 Berberine DIS0053 Diabetes 5A10-5A14 Phase 4 DR00308 Vinblastine DIS0630 Testicular cancer 2C80 Approved DR00308 Vinblastine DIS0084 Hodgkin lymphoma 2B30 Approved DR00308 Vinblastine DIS0204 Bladder cancer 2C94 Approved DR00308 Vinblastine DIS0114 Melanoma 2C30 Approved DR00309 Saquinavir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00311 Ambrisentan DIS0159 Pulmonary arterial hypertension BB01.0 Approved DR00312 Arsenite DIS0058 Discovery agent N.A. Investigative DR00313 Cefadroxil DIS0598 Gram-positive & negative bacteria infections 1A00-1H0Z Approved DR00314 Betaine DIS0097 Inborn error of metabolism 5D2Z Approved DR00316 Oxaliplatin DIS0043 Colorectal cancer 2B91 Approved DR00317 Iron monocation DIS0710 Iron deficiency 5B5K.0 Preclinical DR00318 Pemetrexed DIS0112 Malignant pleural mesothelioma 2C26.0 Approved DR00319 Citalopram DIS0051 Depression 6A8Z Approved DR00320 Ceftizoxime DIS0598 Gram-positive & negative bacteria infections 1A00-1H0Z Approved DR00321 Uridine DIS0051 Depression 6A8Z Approved DR00322 Baricitinib DIS0158 Psoriasis EA90 Approved DR00322 Baricitinib DIS0163 Rheumatoid arthritis FA20 Approved DR00325 Acyclovir DIS0232 Herpes simplex virus infection 1F00 Approved DR00325 Acyclovir DIS0614 Chickenpox 1.00E+90 Approved DR00325 Acyclovir DIS0615 Shingles 1.00E+91 Approved DR00326 Sarcosine DIS0165 Schizophrenia 6A20 Phase 2 DR00327 Benzbromarone DIS0076 Gout FA25 Approved DR00328 Quinolones DIS0175 Tuberculosis 1B1Z Approved DR00329 Glipizide DIS0053 Diabetes 5A10-5A14 Approved DR00330 Cephalexin DIS0599 Gram-positive bacteria infections 1A00-1H0Z Approved DR00331 Sumatriptan DIS0120 Migraine Headaches 8A80 Approved DR00332 Ritonavir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00333 Phenylacetic acid DIS0785 Hyperammonemia 5C50.AY Approved DR00334 Valinomycin DIS0058 Discovery agent N.A. Investigative DR00335 Thiamine pyrophosphate DIS0058 Discovery agent N.A. Investigative DR00336 Hematoporphyrin DIS0058 Discovery agent N.A. Investigative DR00337 N-methylpyridinium DIS0228 Colon cancer 2B90.Z Preclinical DR00338 Manganese DIS0058 Discovery agent N.A. Investigative DR00339 Calcium phosphate DIS0141 Osteoporosis FB83.1 Phase 2 DR00341 Tomatine DIS0058 Discovery agent N.A. Investigative DR00342 Paclitaxel DIS0030 Breast cancer 2C60-2C6Z Approved DR00343 6-Carboxyfluorescein DIS0058 Discovery agent N.A. Investigative DR00344 Fluo-3 DIS0058 Discovery agent N.A. Investigative DR00345 Epipodophyllotoxins DIS0230 External genital and perianal warts 1A95.0, 1A95.1 Preclinical DR00345 Epipodophyllotoxins DIS0234 Molluscum contagiosum infection 1.00E+76 Preclinical DR00347 Olmesartan medoxomil DIS0082 High blood pressure BA00 Approved DR00348 Metildigoxin DIS0046 Congestive heart failure BD10 Preclinical DR00348 Metildigoxin DIS0226 Cardiac arrhythmias BC9Z Preclinical DR00349 Thiourea DIS0058 Discovery agent N.A. Investigative DR00350 D-carnitine DIS0058 Discovery agent N.A. Investigative DR00352 Aspartic acid DIS0058 Discovery agent N.A. Investigative DR00354 Afatinib DIS0132 Non-small cell lung cancer 2C25 Approved DR00355 Calcium phosphate dihydrate DIS0786 Dental Caries DA08.0 Approved DR00357 Vibegron DIS0143 Overactive bladder disorder GC50.0 phase 3 DR00358 Gilteritinib DIS0006 Acute myeloid leukemia 2A60 Approved DR00360 Omadacycline DIS0616 Acute skin infections 1F28.Z Approved DR00360 Omadacycline DIS0640 Community-acquired bacterial pneumonia CA40.0Z Approved DR00362 Ivosidenib DIS0006 Acute myeloid leukemia 2A60 Approved DR00362 Ivosidenib DIS0227 Cholangiocarcinoma 2C12.10 Approved DR00363 Baloxavir marboxil DIS0102 Influenza A infection 1.00E+31 Approved DR00364 Amanitin DIS0058 Discovery agent N.A. Investigative DR00365 Carboxydichlorofluorescein DIS0058 Discovery agent N.A. Investigative DR00366 Talazoparib DIS0030 Breast cancer 2C60-2C6Z Approved DR00367 Azithromycin DIS0647 Traveler's diarrhea ME05.1 Approved DR00367 Azithromycin DIS0636 Middle ear infections AB0Z Approved DR00367 Azithromycin DIS0607 Strep throat 1B51 Approved DR00367 Azithromycin DIS0641 Pneumonia CA40 Approved DR00369 Beta-lactam antibiotics DIS0726 Penicillin allergy QC44.2 Preclinical DR00370 Antiparasitics DIS0031 Cancer 2A00-2F9Z Terminated DR00372 Sofosbuvir DIS0037 Chronic hepatitis C infection 1E51.1 Approved DR00374 Amino acids DIS0133 Nutritional deficiency 5B7Z Approved DR00375 Peptides DIS0679 Bacterial infections 1A00-1H0Z Investigative DR00376 Sodium phosphate dibasic/Sodium phosphate monobasic DIS0058 Discovery agent N.A. Phase 1 DR00379 Melphalan DIS0124 Multiple myeloma 2A83 Approved DR00382 Montelukast DIS0023 Asthma CA23 Approved DR00383 Dolutegravir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00384 Risperidone DIS0165 Schizophrenia 6A20 Approved DR00386 Idarubicin DIS0006 Acute myeloid leukemia 2A60 Approved DR00387 Omeprazole DIS0192 Gastroesophageal reflux disease DA22 Approved DR00389 Methylphenidate DIS0193 Traumatic brain injury NA07.Z Approved DR00390 Fluvoxamine DIS0702 Obsessive compulsive disorder 6B20 Approved DR00391 Cerivastatin DIS0194 Hyperlipidaemia 5C8Z Approved DR00393 Atomoxetine DIS0026 Attention deficit hyperactivity disorder 6A05 Approved DR00395 Carbamazepine DIS0069 Epilepsy 8A6Z Approved DR00396 Nifedipine DIS0019 Angina BA40 Approved DR00397 Vindesine DIS0005 Acute lymphoblastic leukemia 2B33.0 Approved DR00399 Valproic Acid DIS0069 Epilepsy 8A6Z Approved DR00401 Talinolol DIS0718 Gastrointestinal motility disorder DE2Z Phase 1 DR00403 Paroxetine DIS0051 Depression 6A8Z Approved DR00404 Valganciclovir DIS0049 Cytomegalovirus infections 1D82 Approved DR00406 Tacrolimus DIS0140 Organ transplant rejection NE84 Approved DR00407 Nateglinide DIS0053 Diabetes 5A10-5A14 Approved DR00410 Lovastatin DIS0087 Hypercholesterolemia 5C80.0 Approved DR00412 Efavirenz DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00416 Cytarabine DIS0005 Acute lymphoblastic leukemia 2B33.0 Approved DR00416 Cytarabine DIS0040 Chronic myelogenous leukemia 2A20.0 Approved DR00416 Cytarabine DIS0006 Acute myeloid leukemia 2A60 Approved DR00420 Nelfinavir DIS0202 Sars coronavirus infections 1D92 Approved DR00423 Gefitinib DIS0030 Breast cancer 2C60-2C6Z Approved DR00423 Gefitinib DIS0203 Urethral cancer 2F78 Approved DR00423 Gefitinib DIS0132 Non-small cell lung cancer 2C25 Approved DR00423 Gefitinib DIS0142 Ovarian cancer 2C73 Preclinical DR00423 Gefitinib DIS0157 Prostate cancer 2C82 Preclinical DR00425 Cyclophosphamide DIS0618 Lymphomas 2B33.5 Approved DR00426 Haloperidol DIS0165 Schizophrenia 6A20 Approved DR00428 Prednisolone DIS0125 Multiple scierosis 8A40 Approved DR00428 Prednisolone DIS0633 Adrenocortical insufficiency 5A74 Approved DR00428 Prednisolone DIS0163 Rheumatoid arthritis FA20 Approved DR00429 Losartan DIS0082 High blood pressure BA00 Approved DR00430 Fentanyl DIS0205 Analgesia MB40.8 Approved DR00431 Phenytoin DIS0206 Seizures following neurosurgery 8A6Z Approved DR00432 Temsirolimus DIS0160 Renal cell carcinoma 2C90 Approved DR00435 Simvastatin DIS0087 Hypercholesterolemia 5C80.0 Approved DR00436 Metoprolol DIS0019 Angina BA40 Approved DR00436 Metoprolol DIS0082 High blood pressure BA00 Approved DR00438 Prednisone DIS0101 Inflammatory disease 9B72 Approved DR00440 Sertraline DIS0051 Depression 6A8Z Approved DR00442 Rocuronium DIS0209 Muscle relaxant XM31L2 Approved DR00446 Repaglinide DIS0178 Type 2 diabetes 5A11 Approved DR00447 Nevirapine DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00448 Cyclosporine DIS0211 Xerophthalmia 5B55.Y Approved DR00449 Hydroxychloroquine DIS0111 Malaria 1F40 Approved DR00453 Oxcarbazepine DIS0069 Epilepsy 8A6Z Approved DR00454 Sunitinib DIS0010 Advanced renal cell carcinoma 2C90 Approved DR00454 Sunitinib DIS0218 Imatinib-resistant gastrointestinal stromal tumor 2B5B Approved DR00455 Dicloxacillin DIS0600 Susceptible gram-positive bacteria infections 1A00-1H0Z Approved DR00458 Pantoprazole DIS0192 Gastroesophageal reflux disease DA22 Approved DR00459 Fluoxetine DIS0051 Depression 6A8Z Approved DR00462 Olanzapine DIS0165 Schizophrenia 6A20 Approved DR00462 Olanzapine DIS0029 Bipolar disorder 6A60-6A61 Approved DR00464 Anastrozole DIS0030 Breast cancer 2C60-2C6Z Approved DR00466 Ivacaftor DIS0222 Cystic fibrosis CA25 Approved DR00467 Morphine DIS0223 Chronic pain MG30 Approved DR00469 Carboplatin DIS0142 Ovarian cancer 2C73 Approved DR00470 Amitriptyline DIS0189 Major depressive disorder 6A70.3 Approved DR00471 Phenobarbital DIS0224 Seizure 8A68 Approved DR00474 Clozapine DIS0165 Schizophrenia 6A20 Approved DR00476 Clomipramine DIS0051 Depression 6A8Z Approved DR00480 Cyclacillin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00482 Irbesartan DIS0082 High blood pressure BA00 Approved DR00484 Pimozide DIS0165 Schizophrenia 6A20 Approved DR00485 Indocyanine green DIS0277 Gastrointestinal disease DE2Z Approved DR00486 Protriptyline DIS0051 Depression 6A8Z Approved DR00488 Benzylpenicillin DIS0599 Gram-positive bacteria infections 1A00-1H0Z Phase 4 DR00493 Caspofungin DIS0345 Fungal infections 1F20-1F2Z Approved DR00494 Estrone DIS0295 Postmenopausal disorder GA30.Z Approved DR00497 Desloratadine DIS0013 Allergic rhinitis CA08.0 Approved DR00499 Corticosterone DIS0708 Coxarthrosis FA00 Phase 3 DR00500 Ergotamine DIS0280 Headache MB6Y Approved DR00501 Desipramine DIS0026 Attention deficit hyperactivity disorder 6A05 Approved DR00501 Desipramine DIS0051 Depression 6A8Z Approved DR00502 Chlorpromazine DIS0165 Schizophrenia 6A20 Approved DR00507 Lomefloxacin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00509 DIS0058 Discovery agent N.A. Investigative DR00510 Thioguanine DIS0006 Acute myeloid leukemia 2A60 Approved DR00513 Sulfinpyrazone DIS0021 Arthritis FA5Z Approved DR00513 Sulfinpyrazone DIS0076 Gout FA25 Approved DR00514 Darunavir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00517 Ofloxacin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00519 Tauroursodeoxycholate DIS0023 Asthma CA23 Phase 1 DR00521 Clonidine DIS0082 High blood pressure BA00 Approved DR00523 Crizotinib DIS0132 Non-small cell lung cancer 2C25 Approved DR00528 Propranolol DIS0082 High blood pressure BA00 Approved DR00528 Propranolol DIS0298 Migraine 8A80 Approved DR00536 Tubocurarine DIS0221 Anesthesia MB40.3, MB40.8 Approved DR00536 Tubocurarine DIS0316 Smoking withdrawl syndrom 6C4A.2 Approved DR00537 Ceftibuten DIS0265 Chronic bronchitis CA20.1 Approved DR00539 Cefmetazole DIS0644 Urinary tract and skin bacteria infections GC08 Approved DR00541 Loratadine DIS0014 Allergy 4A8Z Approved DR00544 Cephradine DIS0642 Streptococcus pneumoniae infections CA40.0Y Approved DR00546 Cefixime DIS0602 Streptococcus bacterial infections 1C41 Approved DR00547 Fluorescein DIS0258 Ocular disease 9E1Z Approved DR00548 Ethacrynic acid DIS0082 High blood pressure BA00 Approved DR00550 Bromocriptine DIS0178 Type 2 diabetes 5A11 Approved DR00551 Cefamandole DIS0288 Infections by susceptible microorganisms 1H0Z Approved DR00552 Imipramine DIS0189 Major depressive disorder 6A70.3 Approved DR00553 Ceftriaxone DIS0641 Pneumonia CA40 Approved DR00553 Ceftriaxone DIS0636 Middle ear infections AB0Z Approved DR00553 Ceftriaxone DIS0606 Endocarditis 1B41.1 Approved DR00553 Ceftriaxone DIS0613 Meningitis 1D01.Y Approved DR00554 Emetine DIS0282 Hepatitis virus infection 1E5Z Approved DR00556 Salicylic acid DIS0002 Acne vulgaris ED80 Approved DR00556 Salicylic acid DIS0250 Dermatitis EA80-EA8Z Approved DR00557 Hesperetin DIS0199 High cholesterol level 5C80.00 Approved DR00558 Erlotinib DIS0132 Non-small cell lung cancer 2C25 Approved DR00559 Curcumin DIS0031 Cancer 2A00-2F9Z Phase 2 DR00561 Phenformin DIS0053 Diabetes 5A10-5A14 Withdrawn DR00564 Pyrilamide DIS0014 Allergy 4A8Z Approved DR00569 Glycocholic acid DIS0707 Bile acid synthesis defect 5C52.11 Phase 3 DR00572 Chloroquine DIS0111 Malaria 1F40 Approved DR00576 Telithromycin DIS0639 Community acquired pneumonia CA40 Approved DR00577 Cefazolin DIS0609 Methicillin-susceptible staphylococcus aureus 1B74.0 Approved DR00579 Dihydroergocristine DIS0011 Alcohol use disorders 6C40 Approved DR00580 Valspodar DIS0006 Acute myeloid leukemia 2A60 Discontinued in Phase 3 DR00584 Amprenavir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00586 Nitrendipine DIS0082 High blood pressure BA00 Approved DR00588 Abacavir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00590 Trimethoprim DIS0320 Urinary tract infections GC08 Approved DR00594 Ketoconazole DIS0345 Fungal infections 1F20-1F2Z Approved DR00595 Chlorpheniramine DIS0013 Allergic rhinitis CA08.0 Approved DR00595 Chlorpheniramine DIS0257 Urticaria EB00-EB0Y Approved DR00597 Etravirine DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00600 Cefoperazone DIS0610 Pseudomonas bacterial infections 1B92 Approved DR00604 Cephalothin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00607 DIS0058 Discovery agent N.A. Investigative DR00612 Cephaloridine DIS0645 Urinary tract infections GC08 Withdrawn DR00613 Dipyridamole DIS0082 High blood pressure BA00 Approved DR00615 Chenodeoxycholic acid DIS0309 Primary biliary cirrhosis DB96.1 Approved DR00618 Vandetanib DIS0701 Thyroid gland tumours 2D10 Approved DR00619 Delavirdine DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00620 Pramipexole DIS0146 Parkinson's Disease 8A00.0 Approved DR00623 Mefloquine DIS0111 Malaria 1F40 Approved DR00627 Acebutolol DIS0082 High blood pressure BA00 Approved DR00627 Acebutolol DIS0286 Ventricular premature beats BC70 Approved DR00628 Captopril DIS0082 High blood pressure BA00 Approved DR00629 Aldosterone DIS0082 High blood pressure BA00 Approved DR00634 Propafenone DIS0319 Tachyarrhythmias BC71, BC81 Approved DR00636 Reserpine DIS0082 High blood pressure BA00 Approved DR00638 Grepafloxacin DIS0265 Chronic bronchitis CA20.1 Approved DR00641 Genistein DIS0157 Prostate cancer 2C82 Phase 2 DR00642 Amiodarone DIS0319 Tachyarrhythmias BC71, BC81 Approved DR00643 Lansoprazole DIS0149 Peptic ulcer DA61 Approved DR00644 Disopyramide DIS0182 Ventricular arrhythmias BC71 Approved DR00645 Carnosine DIS0165 Schizophrenia 6A20 Phase 2/3 DR00646 Chlorothiazide DIS0065 Edema associated with congestive heart failure BD10 Approved DR00651 Fenofibric acid DIS0087 Hypercholesterolemia 5C80.0 Approved DR00654 Moxalactam DIS0679 Bacterial infections 1A00-1H0Z Approved DR00656 Diltiazem DIS0082 High blood pressure BA00 Approved DR00657 Cholic acid DIS0305 Peroxisomal disorders 5C57.0 Approved DR00657 Cholic acid DIS0306 Synthesis disorders 5C52.10 Approved DR00658 Fluphenazine DIS0311 Psychotic disorders 6A2Z Approved DR00661 Phencyclidine DIS0221 Anesthesia MB40.3, MB40.8 Withdrawn DR00663 Ibuprofen DIS0144 Pain MG30-MG7Z Approved DR00664 Trifluoperazine DIS0165 Schizophrenia 6A20 Approved DR00664 Trifluoperazine DIS0314 Generalized non-psychotic anxiety 6B00 Approved DR00665 Atropine DIS0307 Poison intoxication NE6Z Approved DR00666 Doxycycline DIS0679 Bacterial infections 1A00-1H0Z Approved DR00668 Nisoldipine DIS0082 High blood pressure BA00 Approved DR00669 Clofazimine DIS0700 Leprosy 1B20 Approved DR00672 Emtricitabine DIS0231 Hepatitis B virus infection 1E51.0, 1E50.1 Approved DR00672 Emtricitabine DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00681 Diclofenac DIS0303 Osteoarthritis of knee FA01 Approved DR00684 Midazolam DIS0224 Seizure 8A68 Approved DR00687 Itraconazole DIS0345 Fungal infections 1F20-1F2Z Approved DR00688 Gemifloxacin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00689 Carvedilol DIS0046 Congestive heart failure BD10 Approved DR00691 Felodipine DIS0082 High blood pressure BA00 Approved DR00692 Cefdinir DIS0679 Bacterial infections 1A00-1H0Z Approved DR00693 Prazosin DIS0082 High blood pressure BA00 Approved DR00693 Prazosin DIS0285 Severe congestive heart failure BD10 Approved DR00696 Phenoxybenzamine DIS0291 Malignant phaeochromocytoma 2D11.1 Approved DR00696 Phenoxybenzamine DIS0292 Benign prostatic hypertrophy GA90 Approved DR00696 Phenoxybenzamine DIS0293 Malignant essential hypertension BA00 Approved DR00701 Fosinopril DIS0082 High blood pressure BA00 Approved DR00702 Telaprevir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Approved DR00703 Benzoic acid DIS0345 Fungal infections 1F20-1F2Z Approved DR00704 Cefsulodin DIS0310 Pseudomonas infection CA40.05, KB24 Approved DR00705 Astemizole DIS0013 Allergic rhinitis CA08.0 Withdrawn DR00707 Trichloromethiazide DIS0302 Edema associated with heart failure BD10.Z Approved DR00708 Roxithromycin DIS0679 Bacterial infections 1A00-1H0Z Withdrawn DR00709 Bepridil DIS0266 Chronic stable angina BA40 Approved DR00711 Vemurafenib DIS0296 Metastatic melanoma 2C30 Approved DR00711 Vemurafenib DIS0297 Thyroid cancer 2D10 Approved DR00712 Ampicillin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00713 Clarithromycin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00715 Sulindac DIS0163 Rheumatoid arthritis FA20 Approved DR00716 Vecuronium DIS0144 Pain MG30-MG7Z Approved DR00716 Vecuronium DIS0317 Spasms MB47.3 Approved DR00717 Cordycepin DIS0110 Leukemia 2A60-2B33 Phase 1 DR00718 Tubercidin DIS0058 Discovery agent N.A. Investigative DR00719 Nicotinamide mononucleotide DIS0057 Dietary shortage 5B7Z Preclinical DR00720 Propicillin DIS0601 Streptococcus bacterial infections 1C41 Approved DR00721 Methylurea DIS0058 Discovery agent N.A. Investigative DR00724 Dofetilide DIS0326 Maintenance of normal sinus rhythm BC81.3 Approved DR00725 L-citrulline DIS0712 Congenital heart defects LA8Z Phase 3 DR00730 Maraviroc DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR00733 Dihydrotestosterone DIS0072 Female hypogonadism 5A61.0 Phase 2 DR00745 Linagliptin DIS0178 Type 2 diabetes 5A11 Approved DR00755 Terfenadine DIS0014 Allergy 4A8Z Withdrawn DR00759 Perphenazine DIS0029 Bipolar disorder 6A60-6A61 Approved DR00759 Perphenazine DIS0165 Schizophrenia 6A20 Approved DR00781 Mibefradil DIS0142 Ovarian cancer 2C73 Withdrawn DR00783 Ciprofloxacin DIS0495 Seizure 8A68 Approved DR00785 Thioridazine DIS0165 Schizophrenia 6A20 Approved DR00790 Staurosporine DIS0058 Discovery agent N.A. Phase 2 DR00791 Sparfloxacin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00795 Bicalutamide DIS0157 Prostate cancer 2C82 Approved DR00810 Ziprasidone DIS0165 Schizophrenia 6A20 Approved DR00811 Alprenolol DIS0082 High blood pressure BA00 Withdrawn DR00819 Apatinib DIS0030 Breast cancer 2C60-2C6Z Approved DR00828 Cefoxitin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00831 Gamma-aminobutyric acid DIS0100 Inflammatory bowel disease DD7Z Phase 1/2 DR00833 Naringenin DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Phase 1 DR00836 Bupropion DIS0169 Smoking cessation 6C4A.2 Approved DR00840 Metoclopramide DIS0438 Liver disease DB9Z Approved DR00840 Metoclopramide DIS0502 Vomiting MD90.1 Approved DR00845 Daidzein DIS0706 Low Serum Lipid Levels 5C81 Phase 4 DR00846 Flutamide DIS0157 Prostate cancer 2C82 Approved DR00849 Lidocaine DIS0322 Ventricular tachycardia BC71.0 Approved DR00855 Quetiapine DIS0165 Schizophrenia 6A20 Approved DR00856 Mesalazine DIS0494 Recurrent ventricular fibrillation BC71.1 Approved DR00857 Piperacillin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00883 Camostat DIS0705 Chronic pancreatitis DC32 Approved DR00885 DIS0058 Discovery agent N.A. Investigative DR00886 Nitrofurantoin DIS0497 Termination of pregnancy KD3A Approved DR00892 Gallopamil DIS0023 Asthma CA23 Phase 2 DR00895 Chlorambucil DIS0039 Chronic lymphocytic leukemia 2A82.0 Approved DR00898 DIS0058 Discovery agent N.A. Investigative DR00900 Timolol DIS0082 High blood pressure BA00 Approved DR00904 Adenosine DIS0454 Anxiety MB24.3 Approved DR00905 Sotalol DIS0326 Maintenance of normal sinus rhythm BC81.3 Approved DR00908 Eltrombopag DIS0393 Idiopathic thrombocytopenic purpura 3B64.10 Approved DR00909 Ondansetron DIS0208 Nausea and vomiting associated with chemotherapy MD90 Approved DR00914 Glycyrrhizin DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Approved DR00922 Diethylstilbestrol DIS0347 Gonorrheal vaginitis GA02.1 Approved DR00923 Tecadenoson DIS0429 Paroxysmal supraventricular tachycardia BC81.Z Discontinued in Phase 3 DR00924 DIS0111 Malaria 1F40 Investigative DR00932 Coumestrol DIS0157 Prostate cancer 2C82 Preclinical DR00946 Melagatran DIS0024 Atrial fibrillation BC81.3 Withdrawn DR00948 Glycodeoxycholic acid DIS0023 Asthma CA23 Preclinical DR00950 Phlorizin DIS0058 Discovery agent N.A. Investigative DR00958 Raltitrexed DIS0388 Rectal cancer 2B92 Approved DR00961 Flucloxacillin DIS0679 Bacterial infections 1A00-1H0Z Approved DR00963 Domperidone DIS0391 Gastrointestinal problems DE2Z Approved DR00971 Terbutaline DIS0023 Asthma CA23 Approved DR00974 Cefpodoxime DIS0679 Bacterial infections 1A00-1H0Z Approved DR00979 DIS0058 Discovery agent N.A. Investigative DR00981 Eletriptan DIS0120 Migraine Headaches 8A80 Approved DR00984 Warfarin DIS0024 Atrial fibrillation BC81.3 Approved DR00987 Gamma-hydroxybutyric acid DIS0337 Cerebrovascular disorder 8B2Z Approved DR00988 Chelerythrine DIS0793 Staphylococcus aureus infection 1C41 Preclinical DR00989 Chloramphenicol DIS0679 Bacterial infections 1A00-1H0Z Approved DR00991 Lisinopril DIS0082 High blood pressure BA00 Approved DR00999 Diazepam DIS0454 Anxiety MB24.3 Approved DR01006 Acetaminophen DIS0144 Pain MG30-MG7Z Approved DR01007 Cortisone DIS0442 Atopic dermatitis EA80 Approved DR01010 Epinastine DIS0335 Cardiovascular disorder BA00-BE2Z Approved DR01032 Metolazone DIS0082 High blood pressure BA00 Approved DR01032 Metolazone DIS0046 Congestive heart failure BD10 Approved DR01043 DIS0484 Morphine withdrawal syndrome . Investigative DR01084 DIS0058 Discovery agent N.A. Investigative DR01121 Taurocholic acid DIS0178 Type 2 diabetes 5A11 Terminated DR01132 [3H]Glutamine DIS0058 Discovery agent N.A. Investigative DR01150 DIS0339 Cystine urolithiasis GB7Z Investigative DR01151 DIS0051 Depression 6A8Z Investigative DR01160 Aminosalicylic acid DIS0467 Bed wetting MF50.2Y Approved DR01161 Ajmaline DIS0024 Atrial fibrillation BC81.3 Approved DR01163 Octreotide DIS0326 Maintenance of normal sinus rhythm BC81.3 Approved DR01164 Midodrine DIS0449 Prostate hyperplasia GA90 Approved DR01165 Gatifloxacin DIS0679 Bacterial infections 1A00-1H0Z Approved DR01166 Phenolphthalein DIS0047 Constipation ME05.0 Withdrawn DR01167 Menadione DIS0709 Vitamin K deficiency 5B59 Approved DR01167 Menadione DIS0157 Prostate cancer 2C82 Approved DR01168 Sulpiride DIS0165 Schizophrenia 6A20 Approved DR01170 Toremifene DIS0030 Breast cancer 2C60-2C6Z Approved DR01173 Sodium chloride DIS0375 Severe mood disorders 6A8Z Approved DR01175 Didanosine DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR01177 Hydroxyurea DIS0040 Chronic myelogenous leukemia 2A20.0 Approved DR01184 Nitric oxide DIS0704 Platelet dysfunction 3B62 Phase 2/3 DR01187 Cupric sulfate DIS0053 Diabetes 5A10-5A14 Preclinical DR01187 Cupric sulfate DIS0401 Hyperlipoproteinemia 5C80 Preclinical DR01187 Cupric sulfate DIS0458 Nocturia MF55 Preclinical DR01193 Prasterone DIS0352 Hypercalcemia 5B91.0 Approved DR01194 Cefotiam DIS0345 Fungal infections 1F20-1F2Z Approved DR01195 Rabeprazole DIS0192 Gastroesophageal reflux disease DA22 Approved DR01195 Rabeprazole DIS0149 Peptic ulcer DA61 Approved DR01200 Meropenem DIS0613 Meningitis 1D01.Y Approved DR01200 Meropenem DIS0641 Pneumonia CA40 Approved DR01200 Meropenem DIS0166 Sepsis 1G40-1G41 Approved DR01200 Meropenem DIS0611 Anthrax 1B97 Approved DR01203 Dactinomycin DIS0031 Cancer 2A00-2F9Z Approved DR01204 Norfloxacin DIS0645 Urinary tract infections GC08 Approved DR01204 Norfloxacin DIS0603 Gynecological infections GA6Z Approved DR01208 Eprosartan DIS0082 High blood pressure BA00 Approved DR01211 Nimodipine DIS0336 Cerebral vasospasm BA85.Z Approved DR01212 Mitomycin DIS0454 Anxiety MB24.3 Approved DR01213 Trabectedin DIS0142 Ovarian cancer 2C73 Phase 3 DR01215 Chlorcyclizine DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Phase 1 DR01218 Mycophenolic acid DIS0140 Organ transplant rejection NE84 Approved DR01221 Rosiglitazone DIS0178 Type 2 diabetes 5A11 Approved DR01223 Mephenoxalone DIS0454 Anxiety MB24.3 Preclinical DR01224 DIS0470 Dermatomyositis . Investigative DR01224 DIS0471 Diabetes insipidus . Investigative DR01227 Oxypertine DIS0165 Schizophrenia 6A20 Preclinical DR01231 DIS0058 Discovery agent N.A. Investigative DR01232 Acetylcarnitine DIS0298 Migraine 8A80 Phase 4 DR01234 Phenolsulfonphthalein DIS0058 Discovery agent N.A. Investigative DR01235 Celiprolol DIS0082 High blood pressure BA00 Approved DR01235 Celiprolol DIS0646 Ehlers-Danlos syndrome LD28.1 Approved DR01235 Celiprolol DIS0409 Huntington disease 8A01.10 Preclinical DR01237 Technetium (99MTC) mebrofenin DIS0648 Imaging of liver and gallbladder XD47Y1 Approved DR01241 Milchsaure DIS0116 Metabolic acidosis 5C73 Preclinical DR01241 Milchsaure DIS0334 Cardiotonic XM91S1 Preclinical DR01243 N-acetylaspartylglutamate DIS0713 Vernal Keratoconjunctivitis 9A60.5 Phase 4 DR01245 Dicarboxylate DIS0058 Discovery agent N.A. Investigative DR01246 Succinate DIS0666 Dietary supplements 5B7Z Investigative DR01247 Citrate DIS0722 Acute kidney injury GB60 Preclinical DR01249 Spermine DIS0058 Discovery agent N.A. Preclinical DR01250 Spermidine DIS0654 Plaque psoriasis EA90.0 Preclinical DR01251 Polyamine DIS0727 Subjective cognitive decline MB21.0 Phase 2 DR01252 Monocarboxylic acids DIS0058 Discovery agent N.A. Investigative DR01254 Cation chloride DIS0058 Discovery agent N.A. Investigative DR01255 Pregabalin DIS0069 Epilepsy 8A6Z Approved DR01255 Pregabalin DIS0454 Anxiety MB24.3 Approved DR01255 Pregabalin DIS0659 Neuropathic pain 8E43.0 Approved DR01256 Succimer DIS0649 Lead poisoning NE61 Approved DR01257 Gadobenate dimeglumine DIS0684 CNS imaging XD47Y1 Approved DR01258 Chrysin DIS0666 Dietary supplements 5B7Z Investigative DR01259 Amisulpride DIS0165 Schizophrenia 6A20 Approved DR01259 Amisulpride DIS0665 Dysthymia 6A72 Approved DR01260 Tadalafil DIS0028 Benign prostatic hyperplasia GA90 Approved DR01260 Tadalafil DIS0070 Erectile dysfunction HA01 Approved DR01260 Tadalafil DIS0159 Pulmonary arterial hypertension BB01.0 Approved DR01261 Nadolol DIS0019 Angina BA40 Approved DR01261 Nadolol DIS0082 High blood pressure BA00 Approved DR01262 Actinomycin D DIS0142 Ovarian cancer 2C73 Approved DR01262 Actinomycin D DIS0620 Ewing's sarcoma 2B52 Approved DR01262 Actinomycin D DIS0630 Testicular cancer 2C80 Approved DR01262 Actinomycin D DIS0669 Wilms tumor 2C90.Y Approved DR01262 Actinomycin D DIS0670 Trophoblastic neoplasm 2C75.0 Approved DR01262 Actinomycin D DIS0671 Rhabdomyosarcoma 2B55 Approved DR01263 Penciclovir DIS0232 Herpes simplex virus infection 1F00 Approved DR01264 Apremilast DIS0653 Psoriatic arthritis FA21 Approved DR01264 Apremilast DIS0654 Plaque psoriasis EA90.0 Approved DR01265 Perazine DIS0165 Schizophrenia 6A20 Approved DR01266 Naloxegol DIS0650 Opioid-induced constipation ME05.0 Approved DR01267 Asimadoline DIS0108 Irritable bowel syndrome DD91.0 Phase 3 DR01268 Leupeptin DIS0111 Malaria 1F40 Investigative DR01269 Flavonoids DIS0043 Colorectal cancer 2B91 Phase 2 DR01270 Ibrutinib DIS0039 Chronic lymphocytic leukemia 2A82.0 Approved DR01270 Ibrutinib DIS0672 Mantle cell lymphoma 2A85.5 Approved DR01270 Ibrutinib DIS0673 Waldenstrom's macroglobulinemia 2A85.4 Approved DR01271 Levomepromazine DIS0029 Bipolar disorder 6A60-6A61 Approved DR01271 Levomepromazine DIS0688 Psychosis 6A2Y Approved DR01272 Pyrimethamine DIS0678 Toxoplasmosis 1F57 Approved DR01272 Pyrimethamine DIS0680 Actinomycosis 1C10 Approved DR01272 Pyrimethamine DIS0683 Isosporiasis 1A33.Z Approved DR01273 Azidopine DIS0058 Discovery agent N.A. Investigative DR01274 Fosamprenavir DIS0083 Human immunodeficiency virus infection 1C62.Z Approved DR01275 Entacapone DIS0146 Parkinson's Disease 8A00.0 Approved DR01276 Gramicidin D DIS0679 Bacterial infections 1A00-1H0Z Approved DR01277 Entecavir DIS0038 Chronic hepatitis B infection 1E51.0 Approved DR01278 Zolmitriptan DIS0661 Cluster headaches 8A82 Approved DR01278 Zolmitriptan DIS0662 Migraine with aura 8A80.1 Approved DR01278 Zolmitriptan DIS0663 Migraine without aura 8A80.0 Approved DR01279 Phenprocoumon DIS0174 Thrombosis BD71.4, BD72 Approved DR01279 Phenprocoumon DIS0658 Pulmonary embolism BB00 Approved DR01280 Enoxacin DIS0645 Urinary tract infections GC08 Approved DR01280 Enoxacin DIS0682 Gonorrhea 1A70-1A7Z Approved DR01281 Rizatriptan DIS0120 Migraine Headaches 8A80 Approved DR01282 Naratriptan DIS0120 Migraine Headaches 8A80 Approved DR01283 Tiapamil DIS0655 Cardiovascular disorder BA00-BE2Z Investigative DR01284 Trospium chloride DIS0652 Overactive bladder GC50.0 Approved DR01285 Ixabepilone DIS0030 Breast cancer 2C60-2C6Z Approved DR01286 Pentazocine DIS0122 Moderate to severe pain MG30-MG3Z Approved DR01287 Ortataxel DIS0626 Lung cancer 2C25 Phase 2 DR01287 Ortataxel DIS0668 Kidney cancer 2C90-2C91 Phase 2 DR01287 Ortataxel DIS0676 Glioblastoma 2A00.0 Phase 2 DR01288 Palbociclib DIS0030 Breast cancer 2C60-2C6Z Approved DR01289 Dasabuvir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Phase 3 DR01290 Ledipasvir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Approved DR01291 Pibrentasvir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Approved DR01292 Hoechst 33342 DIS0058 Discovery agent N.A. Investigative DR01293 Pepstatin A DIS0674 Follicular lymphoma 2A80 Preclinical DR01294 Trans-flupentixol DIS0165 Schizophrenia 6A20 Withdrawn DR01295 Clobazam DIS0069 Epilepsy 8A6Z Approved DR01298 Flupentixol DIS0051 Depression 6A8Z Approved DR01298 Flupentixol DIS0165 Schizophrenia 6A20 Approved DR01299 Sunitinib malate DIS0160 Renal cell carcinoma 2C90 Approved DR01299 Sunitinib malate DIS0621 Gastrointestinal stromal tumor 2B5B Approved DR01300 4-(2-Aminoethyl) benzenesulfonyl fluoride DIS0058 Discovery agent N.A. Investigative DR01301 Deoxycholic acid DIS0690 Fat below the chin 5B80 Approved DR01302 Levocetirizine DIS0014 Allergy 4A8Z Approved DR01303 Guanidine DIS0660 Myasthenic syndrome 8C62 Investigative DR01304 Bcecf-Am DIS0058 Discovery agent N.A. Investigative DR01305 Bisantrene DIS0730 Acute myelogenous leukemia 2B33.1 Phase 2 DR01308 Glecaprevir DIS0037 Chronic hepatitis C infection 1E51.1 Phase 2 DR01311 Ombitasvir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Phase 4 DR01312 Paritaprevir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Phase 2 DR01314 Velpatasvir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Phase 1 DR01315 Voxilaprevir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Phase 1 DR01316 Cefodizime DIS0679 Bacterial infections 1A00-1H0Z Approved DR01318 Genistein-7-glucoside DIS0031 Cancer 2A00-2F9Z Investigative DR01318 Genistein-7-glucoside DIS0689 Rotavirus infections 1A22 Investigative DR01319 Temocaprilate DIS0082 High blood pressure BA00 Approved DR01322 Cilostazol DIS0686 Intermittent claudication BD40.00 Approved DR01323 Albendazole DIS0677 Parasitic worm infestations 1F90 Approved DR01324 Carfilzomib DIS0124 Multiple myeloma 2A83 Approved DR01325 Bretylium DIS0656 Ventricular fibrillation BC71.1 Withdrawn DR01326 Thiamphenicol DIS0679 Bacterial infections 1A00-1H0Z Approved DR01326 Thiamphenicol DIS0681 Sexually transmitted infections 1A81, 1A9Y, 1A9Z Approved DR01327 Abiraterone acetate DIS0157 Prostate cancer 2C82 Approved DR01328 Benztropine DIS0146 Parkinson's Disease 8A00.0 Approved DR01328 Benztropine DIS0664 Dystonia 8A02 Approved DR01329 Auranofin DIS0163 Rheumatoid arthritis FA20 Approved DR01330 Clofarabine DIS0005 Acute lymphoblastic leukemia 2B33.0 Approved DR01330 Clofarabine DIS0675 Juvenile myelomonocytic leukemia 2A42 Approved DR01331 Bortezomib DIS0124 Multiple myeloma 2A83 Approved DR01331 Bortezomib DIS0672 Mantle cell lymphoma 2A85.5 Approved DR01332 Bromfenac DIS0651 Ocular pain MC18 Approved DR01332 Bromfenac DIS0687 Ocular inflammation 9C61.24 Approved DR01333 Boceprevir DIS0079 Hepatitis C virus infection 1E50.2, 1E51.1 Approved DR01335 Brexpiprazole DIS0051 Depression 6A8Z Approved DR01335 Brexpiprazole DIS0165 Schizophrenia 6A20 Approved DR01336 Binimetinib DIS0114 Melanoma 2C30 Approved DR01337 Tenofovir alafenamide DIS0038 Chronic hepatitis B infection 1E51.0 Phase 3 DR01337 Tenofovir alafenamide DIS0083 Human immunodeficiency virus infection 1C62.Z Phase 3 DR01338 Metampicillin DIS0679 Bacterial infections 1A00-1H0Z Preclinical DR01339 Gimatecan DIS0753 Brain and central nervous system tumors 2A00 Phase 1/2 DR01340 Nafoxidine DIS0009 Advanced breast cancer 2C60-2C6Z Preclinical DR01341 Triamterene DIS0065 Edema associated with congestive heart failure BD10 Approved DR01343 Vinorelbine DIS0132 Non-small cell lung cancer 2C25 Approved DR01344 Nalbuphine DIS0144 Pain MG30-MG7Z Approved DR01345 Okadaic acid DIS0015 Alzheimer disease 8A20 Preclinical DR01346 Morphine-6-glucuronide DIS0769 Postoperative Pain MG31.2 Phase 3 DR01347 Raloxifene DIS0141 Osteoporosis FB83.1 Approved DR01348 Benzamil DIS0222 Cystic fibrosis CA25 Preclinical DR01349 Karenitecin DIS0142 Ovarian cancer 2C73 Phase 3 DR01350 Flesinoxan DIS0465 Anxiety disorder 6B00 Discontinued in Phase 3 DR01351 TR-14035 DIS0125 Multiple scierosis 8A40 Discontinued in Phase 1 DR01352 Pafenolol DIS0354 Hypertension BA00 Discontinued in Phase 1 DR01353 Isoxicam DIS0446 Osteoarthritis FA0Z Withdrawn DR01354 Nogalamycin DIS0031 Cancer 2A00-2F9Z Preclinical DR01355 Formoterol DIS0023 Asthma CA23 Approved DR01356 Fenoterol DIS0736 Bronchospasm CB40.Y Approved DR01357 Olopatadine DIS0737 Itching of the eye due to allergic conjunctivitis 9A60.02 Approved DR01358 Niguldipine DIS0058 Discovery agent N.A. Terminated DR01359 Triflupromazine DIS0688 Psychosis 6A2Y Approved DR01360 Ceronapril DIS0404 Major depressive disorder 6A70.3 Discontinued in Phase 2 DR01362 Befloxatone DIS0404 Major depressive disorder 6A70.3 Discontinued in Phase 3 DR01363 Tolafentrine DIS0041 Chronic obstructive pulmonary disease CA22 Discontinued in Phase 2 DR01365 ABT-263 DIS0385 Myelofibrosis 2A20.2 Phase 2 DR01366 Dirithromycin DIS0679 Bacterial infections 1A00-1H0Z Approved DR01367 Cycloheximide DIS0345 Fungal infections 1F20-1F2Z Preclinical DR01368 Beclomethasone DIS0487 Perennial and seasonal allergic rhinitis CA08.0 Approved DR01369 Prostaglandin A2 DIS0083 Human immunodeficiency virus infection 1C62.Z Phase 1 DR01370 Midostaurin DIS0006 Acute myeloid leukemia 2A60 Approved DR01371 9-Aminocamptothecin DIS0142 Ovarian cancer 2C73 Phase 2 DR01372 Topiramate DIS0147 Partial seizures 8A68.0 Approved DR01373 Cephaloglycin DIS0679 Bacterial infections 1A00-1H0Z Approved DR01375 Neostigmine DIS0738 Myasthenia gravis 8C60 Approved DR01377 Piritrexim DIS0203 Urethral cancer 2F78 Phase 2 DR01378 99mTc-sestamibi DIS0030 Breast cancer 2C60-2C6Z Approved DR01379 Mequitazine DIS0013 Allergic rhinitis CA08.0 Approved DR01381 BQ-123 DIS0760 ST-Elevation myocardial infarction BA41.0 Phase 2 DR01382 Alfuzosin DIS0028 Benign prostatic hyperplasia GA90 Approved DR01383 Camptothecin DIS0132 Non-small cell lung cancer 2C25 Phase 3 DR01384 Nafcillin DIS0679 Bacterial infections 1A00-1H0Z Approved DR01385 Labetalol DIS0354 Hypertension BA00 Approved DR01386 Cefotetan DIS0679 Bacterial infections 1A00-1H0Z Approved DR01387 Dexniguldipine DIS0031 Cancer 2A00-2F9Z Discontinued in Phase 2 DR01388 Silvestrol DIS0031 Cancer 2A00-2F9Z Preclinical DR01389 Tyramine DIS0146 Parkinson's Disease 8A00.0 Phase 3 DR01390 CP-724714 DIS0030 Breast cancer 2C60-2C6Z Phase 1 DR01391 Clomifene DIS0739 Female infertility GA31 Approved DR01392 Betamethasone DIS0023 Asthma CA23 Approved DR01393 Oxyphenonium DIS0740 Visceral spasms MD81.4 Approved DR01394 Cefditoren DIS0741 Acute bacterial exacerbation of chronic bronchitis CA20.1 Approved DR01395 Triprolidine DIS0013 Allergic rhinitis CA08.0 Approved DR01396 Nifurtimox DIS0775 Human african trypanosomiasis 1F51 Phase 4 DR01397 Pyruvic acid DIS0133 Nutritional deficiency 5B7Z Approved DR01398 Aprepitant DIS0735 Nausea and vomiting MD90 Approved DR01399 Mithramycin DIS0031 Cancer 2A00-2F9Z Withdrawn DR01400 NB-506 DIS0170 Solid tumours 2D4Z Discontinued in Phase 2 DR01401 Tenoxicam DIS0313 Rheumatoid arthritis FA20 Approved DR01403 Substance P DIS0176 Type 1 diabetes 5A10 Phase 1 DR01404 Ximelagatran DIS0058 Discovery agent N.A. Withdrawn DR01405 Phosphatidylserine DIS0765 Familial dysautonomia 8C21 Phase 2 DR01406 Salbutamol DIS0743 Acute asthma CA23 Approved DR01407 Pemirolast DIS0737 Itching of the eye due to allergic conjunctivitis 9A60.02 Approved DR01408 Ciclesonide DIS0023 Asthma CA23 Approved DR01409 Vildagliptin DIS0178 Type 2 diabetes 5A11 Approved DR01410 Guanabenz DIS0354 Hypertension BA00 Approved DR01411 ABT-737 DIS0058 Discovery agent N.A. Terminated DR01412 Glycopyrrolate DIS0744 Airflow obstruction of chronic obstructive pulmonary disease CA22 Approved DR01413 Beta-Acetyldigoxin DIS0655 Cardiovascular disorder BA00-BE2Z Approved DR01414 Beta-Carotene DIS0186 Vitamin deficiency 5B55-5B7Z Approved DR01415 Becatecarin DIS0170 Solid tumours 2D4Z Discontinued in Phase 3 DR01416 Enalaprilat DIS0082 High blood pressure BA00 Approved DR01418 Acrivastine DIS0745 Seasonal allergic rhinitis CA08.01 Approved DR01419 Methysergide DIS0412 Migraine 8A80 Approved DR01420 N1-methylnicotinamide DIS0200 Hypertriglyceridemia 5C80.1 Phase 2 DR01421 Clidinium DIS0149 Peptic ulcer DA61 Approved DR01423 Lurtotecan DIS0142 Ovarian cancer 2C73 Discontinued in Phase 2 DR01424 Droloxifene DIS0030 Breast cancer 2C60-2C6Z Discontinued in Phase 2 DR01425 Ramosetron DIS0108 Irritable bowel syndrome DD91.0 Approved DR01427 Calphostin C DIS0058 Discovery agent N.A. Terminated DR01428 Pirenzepine DIS0149 Peptic ulcer DA61 Approved DR01429 CP-122721 DIS0404 Major depressive disorder 6A70.3 Phase 2 DR01430 Pirarubicin DIS0030 Breast cancer 2C60-2C6Z Approved DR01431 Famciclovir DIS0183 Viral infections 1D90-1D9Z Approved DR01433 Atrasentan DIS0773 Endothelial dysfunction BE2Z Phase 3 DR01434 Trimetrexate DIS0747 Pneumocystis carinii pneumonia CA40.20 Approved DR01435 Estriol DIS0748 Menopausal symptoms MF32 Approved DR01436 Procaterol DIS0023 Asthma CA23 Approved DR01437 UCN-01 DIS0132 Non-small cell lung cancer 2C25 Phase 2 DR01438 Rubitecan DIS0620 Ewing's sarcoma 2B52 Phase 1/2 DR01439 Belotecan DIS0132 Non-small cell lung cancer 2C25 Phase 3 DR01440 5-methyltetrahydrofolate DIS0023 Asthma CA23 Phase 2/3 DR01443 Norverapamil DIS0108 Irritable bowel syndrome DD91.0 Phase 2 DR01444 NSC325663 DIS0041 Chronic obstructive pulmonary disease CA22 Phase 2 DR01445 Hypericin DIS0776 Subclinical anxious adults 6A73 Phase 4 DR01447 E3040 DIS0174 Thrombosis BD71.4, BD72 Discontinued in Phase 2 DR01450 J-107088 DIS0676 Glioblastoma 2A00.0 Phase 3 DR01452 S9788 DIS0031 Cancer 2A00-2F9Z Discontinued in Phase 2 DR01453 SJG-136 DIS0761 Recurrent fallopian tube cancer 2C74 Phase 2 DR01454 Protoporphyrin DIS0710 Iron deficiency 5B5K.0 Preclinical DR01455 Hydroxybupropion DIS0404 Major depressive disorder 6A70.3 Discontinued in Phase 2 DR01459 C-1311 DIS0030 Breast cancer 2C60-2C6Z Phase 2 DR01460 Phenethyl isothiocyanate DIS0031 Cancer 2A00-2F9Z Phase 3 DR01461 AG 337 DIS0626 Lung cancer 2C25 Phase 3 DR01462 M17055 DIS0779 Diuretic vasodilator BA00 Phase 3 DR01463 (-)-Epicatechin DIS0758 Becker muscular dystrophy 8C70.0 Phase 2 DR01464 Cinchonidine DIS0111 Malaria 1F40 Approved DR01466 YM758 DIS0426 Angina pectoris BA40 Phase 2 DR01467 Geneticin DIS0679 Bacterial infections 1A00-1H0Z Preclinical DR01468 Amphotericin B DIS0345 Fungal infections 1F20-1F2Z Approved DR01469 Exatecan mesylate DIS0145 Pancreatic cancer 2C10 Phase 3 DR01471 AG1478 DIS0790 Nasopharyngeal carcinoma 2B6B Preclinical DR01473 Zoledronic acid DIS0746 Paget's disease FB85 Approved DR01474 Tetramethylammonium DIS0278 Glaucoma 9C61 Preclinical DR01475 Butyrate DIS0165 Schizophrenia 6A20 Phase 2/3 DR01478 Quinacrine DIS0157 Prostate cancer 2C82 Phase 2 DR01479 Debrisoquine DIS0354 Hypertension BA00 Approved DR01481 E-guggulsterone DIS0446 Osteoarthritis FA0Z Preclinical DR01483 Ingenol-3-angelate DIS0742 Actinic keratosis EK90.0 Approved DR01484 Apafant DIS0780 Conjunctivitis 9A60 Discontinued in Phase 2 DR01485 Leukotriene E4 DIS0023 Asthma CA23 Preclinical DR01487 4-Hydroxytamoxifen DIS0030 Breast cancer 2C60-2C6Z Phase 3 DR01489 Hydroxycamptothecin DIS0170 Solid tumours 2D4Z Phase 1 DR01490 [D-Ala2, D-Leu5]-enkephalin DIS0144 Pain MG30-MG7Z Preclinical DR01493 Spiperone DIS0165 Schizophrenia 6A20 Approved DR01494 Roscovitine DIS0433 Cystic fibrosis CA25 Phase 2 DR01495 JNJ 7706621 DIS0031 Cancer 2A00-2F9Z Preclinical DR01497 Glycolic acid DIS0778 Melasma ED60.1 Preclinical DR01498 BN-80915 DIS0132 Non-small cell lung cancer 2C25 Phase 2 DR01499 Azasetron DIS0735 Nausea and vomiting MD90 Approved DR01503 Cepharanthine DIS0236 Thrombocytopenia 3B64 Approved DR01505 Dolastatin 10 DIS0110 Leukemia 2A60-2B33 Phase 2 DR01513 Dehydroepiandrosterone sulfate DIS0732 Dyspareunia GA12 Approved DR01514 Bunitrolol DIS0058 Discovery agent N.A. preclinical DR01519 Cefuroxime axetil DIS0679 Bacterial infections 1A00-1H0Z Approved DR01525 Puromycin DIS0679 Bacterial infections 1A00-1H0Z Preclinical DR01528 Temocapril DIS0082 High blood pressure BA00 Approved DR01537 Coelenterazine DIS0789 Inflammatory bowel disease DD7Z Preclinical DR01542 Simvastatin acid DIS0041 Chronic obstructive pulmonary disease CA22 Phase 3 DR01543 Pazufloxacin DIS0768 Bacterial conjunctivitis 9A60 Phase 3 DR01545 Pitavastatin DIS0734 Primary hyperlipidemia and mixed dyslipidemia 5C8Z Approved DR01557 Oxfendazole DIS0755 Trichuris infection 1F6G Phase 2 DR01558 Nonactin DIS0031 Cancer 2A00-2F9Z Preclinical DR01565 Enrofloxacin DIS0679 Bacterial infections 1A00-1H0Z Preclinical DR01570 Homocamptothecin DIS0031 Cancer 2A00-2F9Z Preclinical DR01581 HPPH DIS0626 Lung cancer 2C25 Phase 2 DR01583 Abamectin B1A DIS0677 Parasitic worm infestations 1F90 Preclinical DR01584 Selamectin DIS0289 Infections disease 1H0Z Preclinical DR01586 QSP DIS0777 Acetabular fracture NB52.13 Preclinical DR01591 Mycophenolic acid glucuronide DIS0750 Lung transplantation QB63.2 Phase 1 DR01592 Desmethylsertraline DIS0404 Major depressive disorder 6A70.3 Preclinical DR01601 Pancratistatin DIS0031 Cancer 2A00-2F9Z Preclinical DR01604 Alpha-Zearalenol DIS0032 Cardiovascular disease BE2Z Preclinical DR01605 Taxifolin DIS0142 Ovarian cancer 2C73 Preclinical DR01613 MG-132 DIS0031 Cancer 2A00-2F9Z Preclinical DR01615 Norbuprenorphine DIS0083 Human immunodeficiency virus infection 1C62.Z Phase 1 DR01616 Cholyl lysyl fluorescein DIS0754 Hepatitis virus infection 1E5Z Phase 2 DR01617 Primovist DIS0626 Lung cancer 2C25 Phase 4 DR01618 Benzo(a)pyrene DIS0752 Environmental exposure NF08.Z Phase 1 DR01619 BMS 536924 DIS0031 Cancer 2A00-2F9Z Preclinical DR01623 Eslicarbazepine acetate DIS0147 Partial seizures 8A68.0 Approved DR01626 Genz 644282 DIS0170 Solid tumours 2D4Z Phase 1 DR01627 (Z)-endoxifen DIS0030 Breast cancer 2C60-2C6Z Phase 2 DR01628 Guanfacine DIS0774 Stress disorder 6B40 Phase 4 DR01638 N-desethyl sunitinib DIS0031 Cancer 2A00-2F9Z Preclinical DR01640 Scutellarin DIS0264 Cerebrovascular ischaemia 8B1Z Preclinical DR01643 Fluticasone propionate DIS0023 Asthma CA23 Approved DR01644 Bouvardin DIS0031 Cancer 2A00-2F9Z Preclinical DR01645 Cephaeline DIS0788 Accidental poisoning PB20-PB29 Preclinical DR01649 Metkephamid DIS0144 Pain MG30-MG7Z Preclinical DR01663 Fucoxanthin DIS0756 Metabolic syndrome 5A40-5A4Z Phase 2 DR01664 Crocin DIS0445 Knee osteoarthritis FA01 Phase 3 DR01665 Beclomethasone dipropionate DIS0013 Allergic rhinitis CA08.0 Phase 4 DR01669 Buformin DIS0178 Type 2 diabetes 5A11 Approved DR01670 (R)-Xamoterol DIS0081 Heart failure BD1Z Preclinical DR01671 (S)-Xamoterol DIS0081 Heart failure BD1Z Preclinical DR01676 Epothilone A DIS0031 Cancer 2A00-2F9Z Preclinical DR01679 Lovastatin acid DIS0087 Hypercholesterolemia 5C80.0 Approved DR01687 Sitafloxacin DIS0766 Escherichia Coli Infections 1A03 Phase 2/3 DR01688 Ebastine DIS0108 Irritable bowel syndrome DD91.0 Phase 4 DR01689 Tenofovir disoproxil DIS0038 Chronic hepatitis B infection 1E51.0 Phase 4 DR01696 Benzoylphenylurea DIS0170 Solid tumours 2D4Z Phase 1 DR01698 Glutathione-S-S-glutathione DIS0142 Ovarian cancer 2C73 Phase 2 DR01700 Azidothymidine monophosphate DIS0031 Cancer 2A00-2F9Z Preclinical DR01708 Monomethyl-auristatin-E DIS0031 Cancer 2A00-2F9Z Preclinical DR01712 Barasertib-hQPA DIS0031 Cancer 2A00-2F9Z Preclinical DR01713 S-licarbazepine DIS0147 Partial seizures 8A68.0 Approved DR01715 Parabis DIS0787 Tapeworm infestation 1F7Y Withdrawn DR01717 Saphris DIS0165 Schizophrenia 6A20 Approved DR01721 BMS-3870032 DIS0031 Cancer 2A00-2F9Z Preclinical DR01722 Gepirone DIS0762 Cocaine related disorders 6C45 Phase 2 DR01725 Olamufloxacin DIS0679 Bacterial infections 1A00-1H0Z Approved